NDC 66220-719-01 - KRISTALOSE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66220-719
- Requested NDC
- 66220-719-01
- Package NDCs from labels
- 66220-719-01, 66220-719-30
- Manufacturer
- Cumberland Pharmaceuticals Inc.
- Effective date
- 2018-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| KRISTALOSE - Cumberland Pharmaceuticals Inc. | Cumberland Pharmaceuticals Inc. | 2018-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66220-719-30 | 2022-09-26 | C162847 | 48780-1 | e4f33bdf-9f2d-d8a0-e053-dadaa90a6e4e | KRISTALOSE ® (lactulose) For Oral Solution Cumberland Pharmaceuticals Inc. |
| 66220-719-30 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-9f2d-d8a0-e053-dadaa90a6e4e | KRISTALOSE ® (lactulose) For Oral Solution Cumberland Pharmaceuticals Inc. |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66220-719-01 | KRISTALOSE | 10 g in 1 POUCH | POWDER, FOR SOLUTION | 10 | 4 | |
| 66220-719-30 | KRISTALOSE | 30 in 1 CARTON | POWDER, FOR SOLUTION | 30 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66220-719-01 | EA - Each | 66220-719 | 5ba3d81d-9f5e-4431-ac97-2904210805da | 1 | 2013-08-02 |
| 66220-719-30 | EA - Each | 66220-719 | b760842d-4be8-4ad0-a201-ae8232e8bcba | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| lactulose | ACTIVE INGREDIENT | 9U7D5QH5AE | KRISTALOSE (LACTULOSE) POWDER, FOR SOLUTION [CUMBERLAND PHARMACEUTICALS INC.] | 1 | |
| lactulose | ACTIVE MOIETY | 9U7D5QH5AE | KRISTALOSE (LACTULOSE) POWDER, FOR SOLUTION [CUMBERLAND PHARMACEUTICALS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Generlac | LACTULOSE | Chartwell RX, LLC | 35207edd-a5fe-4369-a079-7a8b0d2f2e91 | 2024-07-16 | Warnings, Adverse reactions | 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | Proficient Rx LP | 6bbabdc6-f6a8-4f67-a448-e452d1928deb | 2024-06-01 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Lactulose Solution | LACTULOSE SOLUTION USP, 10 G/15 ML | Bajaj Medical, LLC | d460b1a2-9091-2ac9-e053-2995a90aa1d2 | 2022-12-26 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Lactulose | LACTULOSE | Fresenius Kabi Austria GmbH | a89835c9-8ce5-4627-8d7d-70ff175b2e07 | 2022-11-09 | Adverse reactions | 9U7D5QH5AE |
| Constulose | LACTULOSE | Actavis Pharma, Inc. | 461ec39f-eeb4-4460-9b5c-62367d47162b | 2022-06-01 | Warnings, Adverse reactions | 9U7D5QH5AE |
| Enulose | LACTULOSE | Actavis Pharma, Inc. | 00c42c5c-d19e-4130-aa08-a8bbd47d3e5b | 2022-06-01 | Warnings, Adverse reactions | 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | Lannett Company, Inc. | 6619b25c-26b7-4c43-8c4f-9d33a23c61ca | 2020-01-30 | Warnings, Adverse reactions | 9U7D5QH5AE |
| KRISTALOSE | LACTULOSE | Cumberland Pharmaceuticals Inc. | 535dd1ea-b567-49f7-9a84-8ea91e78c466 | 2018-09-17 | Warnings, Adverse reactions | ANDA074712 66220-729-01 66220-719-01 66220-729-30 66220-719-30 66220-719 66220-729 66220071901 1251194 1251196 1251192 1251190 85528d56-e38f-4565-9136-c7639b479634 535dd1ea-b567-49f7-9a84-8ea91e78c466 9U7D5QH5AE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.